FI66008C - Foerfarande foer framstaellning av kristallint anhydrat av natrium-7-(d-2-hydroxi-2-fenylacetamido)-3-(1-metyl-1h-tetrazol-5-yltiometyl)-3-cefem-4-karboxylat - Google Patents

Foerfarande foer framstaellning av kristallint anhydrat av natrium-7-(d-2-hydroxi-2-fenylacetamido)-3-(1-metyl-1h-tetrazol-5-yltiometyl)-3-cefem-4-karboxylat Download PDF

Info

Publication number
FI66008C
FI66008C FI763682A FI763682A FI66008C FI 66008 C FI66008 C FI 66008C FI 763682 A FI763682 A FI 763682A FI 763682 A FI763682 A FI 763682A FI 66008 C FI66008 C FI 66008C
Authority
FI
Finland
Prior art keywords
sodium
crystalline
methyl
anhydrate
monohydrate
Prior art date
Application number
FI763682A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI66008B (fi
FI763682A (es
Inventor
Kuo-Shang Yang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI763682A publication Critical patent/FI763682A/fi
Priority to FI834617A priority Critical patent/FI67554C/fi
Publication of FI66008B publication Critical patent/FI66008B/fi
Application granted granted Critical
Publication of FI66008C publication Critical patent/FI66008C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI763682A 1975-12-22 1976-12-22 Foerfarande foer framstaellning av kristallint anhydrat av natrium-7-(d-2-hydroxi-2-fenylacetamido)-3-(1-metyl-1h-tetrazol-5-yltiometyl)-3-cefem-4-karboxylat FI66008C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI834617A FI67554C (fi) 1975-12-22 1983-12-15 Vid framstaellning av kristallinskt natriumcefamandolianhydratsaosom mellanprodukt anvaent kristallinsk metanolsolvat a v atrium-7-(d-2-hydroxi-2-fenylacetamido)-3-(1-metyl-1h-tet raol-5-yltiometyl)-3-cefem-4-karboxylat och foerfarande foe r ess framstaellning

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64292275 1975-12-22
US05/642,922 US4054738A (en) 1975-12-22 1975-12-22 Sodium cefamandole crystalline forms

Publications (3)

Publication Number Publication Date
FI763682A FI763682A (es) 1977-06-23
FI66008B FI66008B (fi) 1984-04-30
FI66008C true FI66008C (fi) 1984-08-10

Family

ID=24578600

Family Applications (1)

Application Number Title Priority Date Filing Date
FI763682A FI66008C (fi) 1975-12-22 1976-12-22 Foerfarande foer framstaellning av kristallint anhydrat av natrium-7-(d-2-hydroxi-2-fenylacetamido)-3-(1-metyl-1h-tetrazol-5-yltiometyl)-3-cefem-4-karboxylat

Country Status (31)

Country Link
US (1) US4054738A (es)
JP (2) JPS5282714A (es)
AR (1) AR213300A1 (es)
AT (2) AT349148B (es)
AU (1) AU505924B2 (es)
BE (1) BE849415A (es)
CA (1) CA1080696A (es)
CH (1) CH628348A5 (es)
CS (1) CS195746B2 (es)
DD (1) DD128727A5 (es)
DE (1) DE2654647C2 (es)
DK (1) DK153156C (es)
FI (1) FI66008C (es)
FR (3) FR2361898A1 (es)
GB (1) GB1565854A (es)
GR (1) GR65891B (es)
HU (1) HU172474B (es)
IL (3) IL50977A (es)
LU (1) LU76435A1 (es)
MX (1) MX3840E (es)
NL (1) NL187483C (es)
NO (1) NO148887C (es)
NZ (1) NZ182694A (es)
OA (1) OA05518A (es)
PH (1) PH12191A (es)
PL (1) PL102739B1 (es)
PT (1) PT65955B (es)
RO (3) RO75963A (es)
SE (3) SE424730B (es)
SU (3) SU637087A3 (es)
ZA (1) ZA766957B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4168376A (en) * 1978-06-05 1979-09-18 Eli Lilly And Company Process for crystalline sodium cefamandole
US4237279A (en) * 1979-07-27 1980-12-02 Eli Lilly And Company Crystalline 3-hydroxycephalosporin solvates
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3313816A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
CA1242699A (en) * 1985-02-01 1988-10-04 Bristol-Myers Company Cefbuperazone and derivatives thereof
JPH0677412B2 (ja) * 1985-05-03 1994-09-28 株式会社フジクラ 高圧直流送電用電力ケーブル
JPS629495U (es) * 1985-07-01 1987-01-21
GB9717629D0 (en) 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3496171A (en) * 1969-02-17 1970-02-17 Lilly Co Eli Process for improving the physical and chemical properties of cephaloglycin
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
US3692781A (en) * 1971-02-26 1972-09-19 Glaxo Lab Ltd Recovery of pure cephalexin from acidic reaction mixtures
US3819620A (en) * 1972-06-01 1974-06-25 Squibb & Sons Inc 7-(d-alpha-amino-1,4-cyclohexadien-1-ylacet-amido)desacetoxycephalosporanic acid dihydrate
US3862186A (en) * 1972-12-15 1975-01-21 Bristol Myers Co Process for the production of cephalexin monohydrate
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions

Also Published As

Publication number Publication date
SU1018585A3 (ru) 1983-05-15
NL187483B (nl) 1991-05-16
NL187483C (nl) 1991-10-16
SU637087A3 (ru) 1978-12-05
FR2351985B1 (es) 1980-06-27
FI66008B (fi) 1984-04-30
AU505924B2 (en) 1979-12-06
JPS61351B2 (es) 1986-01-08
NZ182694A (en) 1978-09-25
NO764222L (es) 1977-06-23
FR2351984B1 (es) 1980-06-27
FI763682A (es) 1977-06-23
ATA217578A (de) 1978-08-15
DK153156B (da) 1988-06-20
ATA948976A (de) 1978-07-15
MX3840E (es) 1981-08-11
HU172474B (hu) 1978-09-28
ZA766957B (en) 1978-06-28
IL50977A (en) 1980-02-29
DE2654647A1 (de) 1977-06-30
RO69709A (ro) 1980-04-15
BE849415A (fr) 1977-06-15
RO75963A (ro) 1981-02-28
IL57386A0 (en) 1979-09-30
JPS6183189A (ja) 1986-04-26
SE424730B (sv) 1982-08-09
JPS5282714A (en) 1977-07-11
NO148887B (no) 1983-09-26
CS195746B2 (en) 1980-02-29
SU671732A3 (ru) 1979-06-30
NL7614233A (nl) 1977-06-24
SE7614401L (sv) 1977-06-23
RO75964A (ro) 1981-02-28
IL57387A0 (en) 1979-09-30
DK153156C (da) 1989-02-20
FR2361898A1 (fr) 1978-03-17
GR65891B (es) 1980-12-01
DE2654647C2 (de) 1982-06-24
JPS624393B2 (es) 1987-01-30
NO148887C (no) 1984-01-04
PH12191A (en) 1978-11-21
CA1080696A (en) 1980-07-01
LU76435A1 (es) 1977-06-10
FR2351985A1 (fr) 1977-12-16
AT349148B (de) 1979-03-26
SE8201701L (sv) 1982-03-17
SE441096B (sv) 1985-09-09
FR2361898B1 (es) 1980-03-14
FR2351984A1 (fr) 1977-12-16
US4054738A (en) 1977-10-18
PT65955B (en) 1978-06-15
GB1565854A (en) 1980-04-23
IL50977A0 (en) 1977-01-31
SE443564B (sv) 1986-03-03
AU2001376A (en) 1978-06-01
SE8201702L (sv) 1982-03-17
PT65955A (en) 1977-01-01
OA05518A (fr) 1981-04-30
DD128727A5 (de) 1977-12-07
CH628348A5 (de) 1982-02-26
AT348678B (de) 1979-02-26
AR213300A1 (es) 1979-01-15
PL102739B1 (pl) 1979-04-30
DK575576A (da) 1977-06-23

Similar Documents

Publication Publication Date Title
US4910301A (en) Cefepime cephalosporin salts
FI72978C (fi) Foerfarande foer franstaellning av som laekemedel anvaendbara alkyl-(eller alkoxi-)-karbonyloxialkyl-7-/2-(2- aminotiazol-4-yl)-2-hydroxiiminoacetamido/-3-metoximetyl-3-cefem-4- karboxylat.
FI66008C (fi) Foerfarande foer framstaellning av kristallint anhydrat av natrium-7-(d-2-hydroxi-2-fenylacetamido)-3-(1-metyl-1h-tetrazol-5-yltiometyl)-3-cefem-4-karboxylat
US20050080255A1 (en) Crystalline cefdinir potassium dihydrate
WO2017140072A1 (zh) 一种采用粒子过程晶体产品分子组装与形态优化技术的头孢呋辛钠新晶型化合物及制剂
KR20180040732A (ko) 퀴놀린 화합물의 결정형 및 그의 제조 방법
HU196602B (en) Process for producing acid-addition salts of 7-square brackets open alpha-(aminothiazol-4-yl)-alpha-/z/-methoxy-imino-acetamido square brackets closed -3-square brackets open (1-methyl-1-pyrrolidino)-methyl square brackets closed -3-cefem-4-carboxilate, as well as dry mixtures thereof formed with bases and suitable for producing injectable solutions
KR0123015B1 (ko) 세프타지딤 이염산염 포름산 용매화물
AU2006300882A1 (en) Crystalline sodium salt of cephalosporin antibiotic
FI62311B (fi) Foerfarande foer framstaellning av kristallint natrium- och kaiumcefalexinmonohydrat
IL94701A (en) Saffam crystalline acid adsorption salts, processes for their preparation and pharmaceutical preparations containing them
FI67554C (fi) Vid framstaellning av kristallinskt natriumcefamandolianhydratsaosom mellanprodukt anvaent kristallinsk metanolsolvat a v atrium-7-(d-2-hydroxi-2-fenylacetamido)-3-(1-metyl-1h-tet raol-5-yltiometyl)-3-cefem-4-karboxylat och foerfarande foe r ess framstaellning
CA1089446A (en) Sodium cefamandole crystalline forms
US4994451A (en) Cephalosporin salts and injectable compositions
CA1089447A (en) Sodium cefamandole crystalline forms
CA1200544A (en) Crystalline cephalosporin
CA1122974A (en) Process for crystalline sodium cefamandole
JPS606958B2 (ja) 抗生物質の精製法
US3947415A (en) Cefamandole derivatives
US4680389A (en) Temperature stable crystalline di(1-methyl-2-pyrralidinone) and di(N-formylpyrrolidine) adducts of cephalosporin derivatives
CS195748B2 (cs) Způsob výroby krystalické bezvodé sodné solí cefamandolu
SU1757469A3 (ru) Способ получени устойчивой кристаллической формы цефалоспоринов
WO2004110399A2 (en) Solvates of cefprozil
DK158355B (da) Fremgangsmaade til fremstilling af det krystallinske methanolsolvat af natriumcefamandol

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: ELI LILLY AND COMPANY